Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent m...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Routledge
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193265/ |